Generic antibiotics, antibiotic resistance, and drug licensing

The Lancet Infectious Diseases

Volumn 10, Issue 11, 2010, Pages 754-

  Finch, Roger ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; GENERIC DRUG; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; BIOEQUIVALENCE; ESCHERICHIA COLI; HEALTH CARE; HEALTH SERVICE; INFECTION; LETTER; LICENSING; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG APPROVAL; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; DRUGS, GENERIC; HUMANS; PRESCRIPTIONS;

EID: 78049400715     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(10)70246-2     Document Type: Letter

References (4)

1. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010, 10:597-602.
2. CBS Health News, (accessed Aug 17, 2010). http://www.cbsnews.com/stories/2007/08/07/health/main3140185.shtml.
3. European Committee on Antimicrobial Susceptibility Testing (EUCAST), (accessed Aug 17, 2010). http://www.eucast.org.
4. British Society for Antimicrobial Chemotherapy, (accessed Aug 17, 2010). http://www.bsacsurv.org.